VOLUME
68 2007 NUMBER 5
Editorial
653 Call for Papers From Early Career Psychiatrists. Marlene P. Freeman and Alan J. Gelenberg
[PDF]
Original Articles
654 Guided Discontinuation Versus Maintenance Treatment in Remitted
First-Episode Psychosis: Relapse Rates and Functional Outcome. Lex
Wunderink, Fokko J. Nienhuis, Sjoerd Sytema, Cees J. Slooff, Rikus
Knegtering, and Durk Wiersma
[Abstract] [PDF]
662 Aripiprazole Effects in Patients With Acute Schizophrenia
Experiencing Higher or Lower Agitation: A Post Hoc Analysis of 4 Randomized,
Placebo-Controlled Clinical Trials. Stephen R. Marder, Britt West, Gina
S. Lau, Joseph A. Pultz, Andrei Pikalov, Ronald N. Marcus, Rolando
Gutierrez-Esteinou, and David T. Crandall
[Abstract] [PDF]
677 A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety
of Desvenlafaxine Succinate in the Treatment of Major Depressive Disorder.
Nicholas A. DeMartinis, Paul P. Yeung, Richard Entsuah, and Amy L. Manley
[Abstract] [PDF]
689 Decisional Capacity to Consent to Research Among Patients With
Bipolar Disorder: Comparison With Schizophrenia Patients and Healthy
Subjects. Barton W. Palmer, Laura B. Dunn, Colin A. Depp, Lisa T. Eyler,
and Dilip V. Jeste
[Abstract] [PDF]
697 Impact of CYP1A2 and CYP2D6 Polymorphisms on Drug
Metabolism and on Insulin and Lipid Elevations and Insulin Resistance in
Clozapine-Treated Patients. Kristina I. Melkersson, M. Gabriella Scordo,
Arzu Gunes, and Marja-Liisa Dahl
[Abstract] [PDF]
705 A Randomized, Double-Blind, Placebo-Controlled Trial of Modafinil for
Negative Symptoms in Schizophrenia. Joseph M. Pierre, John H. Peloian,
Donna A. Wirshing, William C. Wirshing, and Stephen R. Marder
[Abstract] [PDF]
711 Randomized, Double-Blind Comparison of Sertraline and Placebo for
Posttraumatic Stress Disorder in a Department of Veterans Affairs Setting.
Matthew J. Friedman, Charles R. Marmar, Dewleen G. Baker, Carolyn R.
Sikes, and Gail M. Farfel
[Abstract] [PDF]
721 Risk Factors for Suicide Completion in Borderline Personality
Disorder: A Case-Control Study of Cluster B Comorbidity and Impulsive
Aggression. Alexander McGirr, Joel Paris, Alain Lesage, Johanne Renaud,
and Gustavo Turecki
[Abstract] [PDF]
730 Randomized Controlled Trial of Cognitive Behavioral Social Skills
Training for Older People With Schizophrenia: 12-Month Follow-Up. Eric
Granholm, John R. McQuaid, Fauzia Simjee McClure, Peter C. Link, Dimitri
Perivoliotis, Jennifer D. Gottlieb, Thomas L. Patterson, and Dilip V. Jeste
[Abstract] [PDF]
738 Natural Course of Bulimia Nervosa and of Eating Disorder Not
Otherwise Specified: 5-Year Prospective Study of Remissions, Relapses, and
the Effects of Personality Disorder Psychopathology.
[CME] Carlos M. Grilo, Maria E. Pagano, Andrew E. Skodol,
Charles A. Sanislow, Thomas H. McGlashan, John G. Gunderson, and Robert L.
Stout
[Abstract] [PDF]
747 Prediction of Response to Paroxetine and Venlafaxine by
Serotonin-Related Genes in Obsessive-Compulsive Disorder in a Randomized,
Double-Blind Trial. Damiaan Denys, Filip Van Nieuwerburgh, Dieter Deforce,
and Herman G. M. Westenberg
[Abstract] [PDF]
754 Disrupted Antioxidant Enzyme Activity and Elevated Lipid Peroxidation
Products in Schizophrenic Patients With Tardive Dyskinesia. Xiang Yang
Zhang, Yun Long Tan, Dong Feng Zhou, Lian Yuan Cao, Gui Ying Wu, Colin N.
Haile, Therese A. Kosten, and Thomas R. Kosten
[Abstract] [PDF]
761 Duloxetine Treatment of Dysthymia and Double Depression: An
Open-Label Trial. Lorrin M. Koran, Elias N. Aboujaoude, and Nona N. Gamel
[Abstract] [PDF]
Commentary
669 Exercise for Mood and Anxiety Disorders. [CME]
Michael W. Otto, Timothy S. Church, Lynette L. Craft, Tracy L.
Greer, Jasper A. J. Smits, and Madhukar H. Trivedi
[PDF]
Focus on Childhood and Adolescent Mental Health
766 "An Ounce of Prevention Is Worth a Pound of Cure." Melissa P.
DelBello
[PDF]
767 Impact of Severity of Substance Use Disorder on Symptomatic and
Functional Outcome in Young Individuals With First-Episode Psychosis.
Darryl Wade, Susy Harrigan, Patrick D. McGorry, Philip M. Burgess, and Greg
Whelan
[Abstract] [PDF]
775 Regular Daily Smoking Among 14-Year-Old Adolescents Increases the
Subsequent Risk for Suicide: The Northern Finland 1966 Birth Cohort Study.
Kaisa Riala, Antti Alaräisänen, Anja Taanila, Helinä Hakko, Markku
Timonen, and Pirkko Räsänen
[Abstract] [PDF]
781 Double-Blind, Placebo-Controlled Trial of Divalproex Monotherapy in
the Treatment of Symptomatic Youth at High Risk for Developing Bipolar
Disorder. Robert L. Findling, Thomas W. Frazier, Eric A. Youngstrom, Nora
K. McNamara, Robert J. Stansbrey, Barbara L. Gracious, Michael D. Reed,
Christine A. Demeter, and Joseph R. Calabrese
[Abstract] [PDF]
789 A 12-Week Single-Blind Trial of Quetiapine for the Treatment of Mood
Symptoms in Adolescents at High Risk for Developing Bipolar I Disorder.
Melissa P. DelBello, Caleb M. Adler, Rachel M. Whitsel, Kevin E. Stanford,
and Stephen M. Strakowski
[Abstract] [PDF]
ASCP Corner
796 Psychopharmacology in the Emergency Room. Michael D. Jibson
[PDF]
Letters To the Editor
798 Resolution of Late-Onset Hypomania After Repair of Carotid Artery
Stenosis: A Case of Vascular Hypomania. Abigail L. Donovan and Oliver
Freudenreich
[PDF]
798 Augmentation of Clozapine Treatment With Aripiprazole. Sabina Lim
and Malcolm B. Bowers
[PDF]
799 What Do We Know About Insulin Resistance and Glucose Metabolism in
Patients With Schizophrenia Treated With Antipsychotics? Jamie Karagianis,
Vicki Poole Hoffmann, Virginia L. Stauffer, and Tamás Treuer
[PDF]
- Replies by Belen Arranz and Luis San, and David C. Henderson
802 Decreased Lipoprotein Lipase as a Risk Factor for Atypical
Neuroleptic-Induced Hypertriglyceridemia. Kenji Yamamoto, Masamichi
Fukuda, Akiko Nogawa, Eri Takahashi, and Hitoshi Miyaoka
[PDF]
803 A Case Report of Reemergence of Antipsychotic-Induced Dyskinesia With
Citalopram. Harpreet S. Duggal and Dattatreya N. Mendhekar
[PDF]
803 A Pilot Observational Crossover Study of QTc Interval Changes
Associated With Switching Between Olanzapine and Risperidone. Chieh-Liang
Huang, Kuan-Pin Su, Hsiu-Bao Hsu, and Carmine M. Pariante
[PDF]
805 Aripiprazole and Worsening of Psychosis: A Case Report. Niraj
Ahuja and Adrian J. Lloyd
[PDF]
806 Correction. Endicott J, Russell JM, Raskin J, Detke MJ, Erickson
J, Ball SG, Marciniak M, and Swindle RW. Duloxetine treatment for role
functioning improvement in generalized anxiety disorder: three independent
studies (J Clin Psychiatry 2007;68:518-524)
[PDF]
Book Reviews 807
Electronic CME Activities
Available through www.psychiatrist.com/toc
e12 Series Introduction and Cardiovascular Disease in Patients With Schizophrenia. John W. Newcomer and Charles H. Hennekens
e13 Evidence of Switching Antipsychotic Therapy to Improve Metabolic Disturbances. Peter J. Weiden and John W. Newcomer